CD38 targeting in multiple myeloma

被引：0
|
作者：
Abel, Andrea [1 ]
Cano, Laia Querol [1 ]
van Spriel, Annemiek [1 ]
Hammink, Roel [1 ]
ter Beest, Martin [1 ]
机构：
[1] Radboud Inst Mol Life Sci RIMLS, Nijmegen, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-377
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [31] CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance
    van de Donk, Niels W. C. J.
    Usmani, Saad Z.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [32] EVALUATION OF CD38 AS TARGET FOR IMMUNOTHERAPY IN MULTIPLE-MYELOMA - RESPONSE
    GOLDMACHER, VS
    LAMBERT, JM
    ANDERSON, KC
    BLOOD, 1995, 85 (08) : 2283 - 2284
  • [33] Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies
    Wu, Hao-Tian
    Zhao, Xiang-Yu
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (05): : 1974 - 1988
  • [34] Monoclonal Antibodies for the Treatment of Myeloma Targeting SLAMF7 and CD38
    Lonial, Sagar
    CANCER JOURNAL, 2016, 22 (01): : 3 - 6
  • [35] CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma
    Cuollo, Lorenzo
    Di Cristofano, Samuele
    Sandomenico, Annamaria
    Iaccarino, Emanuela
    Oliver, Angela
    Zingoni, Alessandra
    Cippitelli, Marco
    Fionda, Cinzia
    Petillo, Sara
    Kosta, Andrea
    Tassinari, Valentina
    Petrucci, Maria Teresa
    Fazio, Francesca
    Ruvo, Menotti
    Santoni, Angela
    Raimondo, Domenico
    Soriani, Alessandra
    ISCIENCE, 2024, 27 (05)
  • [36] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Mei, Heng
    Li, Chenggong
    Jiang, Huiwen
    Zhao, Xinying
    Huang, Zhiping
    Jin, Dan
    Guo, Tao
    Kou, Haiming
    Liu, Lin
    Tang, Lu
    Yin, Ping
    Wang, Zhihui
    Ai, Lisha
    Ke, Sha
    Xia, Yimeng
    Deng, Jun
    Chen, Lei
    Cai, Li
    Sun, Chunyan
    Xia, Linghui
    Hua, Gaoquan
    Hu, Yu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [37] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Heng Mei
    Chenggong Li
    Huiwen Jiang
    Xinying Zhao
    Zhiping Huang
    Dan Jin
    Tao Guo
    Haiming Kou
    Lin Liu
    Lu Tang
    Ping Yin
    Zhihui Wang
    Lisha Ai
    Sha Ke
    Yimeng Xia
    Jun Deng
    Lei Chen
    Li Cai
    Chunyan Sun
    Linghui Xia
    Gaoquan Hua
    Yu Hu
    Journal of Hematology & Oncology, 14
  • [38] MT-4019: a de-immunized engineered toxin body targeting CD38 for multiple myeloma
    Robinson, Garrett L.
    Rajagopalan, Sangeetha
    Brieschke, Brigitte
    Neill, Jane
    Erdman, Jennifer
    Flores, Rodney
    Liu, Jensing
    Higgins, Jack P.
    Willert, Erin K.
    CANCER RESEARCH, 2017, 77
  • [39] Targeting CD38 for acute leukemia
    Zhong, Xushu
    Ma, Hongbing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Characterization of the Therapeutic Effects of Novel Chimeric Antigen Receptor T Cells Targeting CD38 on Multiple Myeloma
    Li, Xiaorui
    Feng, Yaru
    Shang, Fengqin
    Yu, Zhuoying
    Wang, Tieshan
    Zhang, Jing
    Song, Zhiru
    Wang, Ping
    Shi, Bingjie
    Wang, Jianxun
    FRONTIERS IN ONCOLOGY, 2021, 11
12345